Mapi Pharma
Latest round
- Series A
Last raised
- May 2015
Total raised
- $10M
Investors
- 1
About Mapi Pharma
Mapi Pharma Ltd.Founded in 2008 and headquartered in Israel, Mapi Pharma Ltd. focuses on developing advanced pharmaceuticals.Mapi Pharma Ltd. specializes in the development and manufacture of innovative long-acting depot injectable pharmaceuticals, primarily targeting conditions such as multiple sclerosis (MS) and neuropathic pain. The company's lead product, Glatiramer Acetate (GA) Depot, is a once-monthly intramuscular injection designed to treat various forms of MS, addressing a significant market valued at approximately USD 20 bn. Additionally, Mapi Pharma is advancing other formulations such as long-acting Pregabalin for pain management, as well as Paliperidone Palmitate and Buspirone ER for treating schizophrenia. These products are aimed at enhancing patient adherence and outcomes by reducing the frequency of injections.Revenue generation for Mapi Pharma is largely driven through partnerships and business-to-business transactions with healthcare providers and pharmaceutical distributors. The transactions typically involve the sale of its flagship products, including GA Depot and Pregabalin ER, through established distribution networks that supply hospitals and clinics. Pricing structures are typically determined based on contracts with healthcare institutions and pharmaceutical wholesalers, facilitating bulk purchasing agreements and tiered pricing that reflect order volumes. The company is currently developing new formulations, including long-acting versions of Pregabalin, with plans for launch in the next 24 months. Mapi Pharma is targeting expansion into additional European markets to increase its footprint by 2025, aiming to deliver on its commitment to enhance treatment options for patients with chronic conditions.
Who invested in Mapi Pharma
1 investor across 1 round
See all investors in Mapi Pharma
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series A
May 27, 2015
Amount
$10M
Investors
Questions about Mapi Pharma
Who invested in Mapi Pharma?
Mapi Pharma has 1 investor on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Mapi Pharma raised?
Mapi Pharma has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did Mapi Pharma last raise money?
Mapi Pharma's most recent round on record is a Series A, in May 2015.
What does Mapi Pharma do?
Mapi Pharma is a pharmaceuticals company.
Where is Mapi Pharma headquartered?
Mapi Pharma is headquartered in Israel.
Which VCs invest in companies like Mapi Pharma?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Hui Hua Fund, Yufu Capital and ICBC Capital Management back pharmaceuticals companies at Mapi Pharma's stage. Their profiles are linked below.
VCs backing pharmaceuticals startups at Series A
Raising like Mapi Pharma? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.